Table 1.
Demographic and clinical parameters of the included subjects.
| Variable | ITB (n = 27) |
CD (n = 25) |
P-value |
|---|---|---|---|
| Baseline characteristics | |||
| Age (yr) (mean ± sd) | 32.53 ± 12.02 | 32.7 ± 12.5 | 0.97 |
| Sex (F/M) | 12/15 | 10/15 | |
| Duration of disease (month) | 10 (2–78) | 8 (2–180) | 0.5 |
| Fever (Y/N) | 20/7 | 19/6 | 0.96 |
| Pain abdomen (Y/N) | 23/4 | 21/4 | 0.99 |
| Weight loss (Y/N) | 24/3 | 20/5 | 0.97 |
| Gola formation (Y/N) | 21/6 | 15/10 | 0.17 |
| Clinical characteristics | |||
| Location (%) | |||
| Terminal ileal | 6 (22) | 10 (40) | 0.57 |
| Ileocecal | 21 (78) | 9 (36) | 0.02 |
| Colonic | 0 (00) | 6 (24) | 0.77 |
| Hemoglobin (gm/dl) (mean ± sd) | 10.68 ± 1.57 | 9.61 ± 3.4 | 0.81 |
| ESR (mm) (mean ± sd) | 47 ± 23.92 | 52.1 ± 21.8 | 0.7 |
| CRP (mg/dl) [median (range)] | 1.1 (0.7–43.8) | 1.74 (0.3–4.7) | 0.60 |
| Histological status | |||
| Granulomatous iletis (%) | 9 (33) | 6 (24) | 0.97 |
| Chronic active iletis (%) | 0 (00) | 7 (28) | 0.03 |
| Non-specific inflammation (%) | 17 (63) | 12 (48) | 0.74 |
| TB PCR positive (%) | 27(100) | 0 (00) | 6.30E−11 |